The DOI matches its Crossref record; 167 of the 167 references it cites were found in a registry or an index.
Directing cancer cells to self-destruct with pro-apoptotic receptor agonists
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
RETRACTED: Death-receptor activation halts clathrin-dependent endocytosis
Austin, C. D., Lawrence, D. A., Peden, A. A., Varfolomeev, E. E., Tótpál, K., Mazière, A. M. G. L. D., Klumperman, J., Arnott, D. P., Pham, V. C., Scheller, R. H., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604044103 · Cited by 116
Self-citationRetractedBaritaki, S., Katsman, A., Chatterjee, D., Yeung, K. C., Spandidos, D. A., & Bonavida, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5441 · Cited by 99
RetractedHanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Apoptosis: A Review of Programmed Cell Death
Elmore, S. (2007) · Toxicologic Pathology · doi:10.1080/01926230701320337 · Cited by 13,853
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Self-citationAkt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Nagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,938
Live or let die: the cell's response to p53
Vousden, K. H., & Lu, X. (2002) · Nature Reviews Cancer · doi:10.1038/nrc864 · Cited by 3,192
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes
Micheau, O., & Tschopp, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00521-x · Cited by 2,738
NF-κB at the crossroads of life and death
Karin, M., & Lin, A. (2002) · Nature Immunology · doi:10.1038/ni0302-221 · Cited by 2,709
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Self-citationDeath and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
Induction of Apoptosis by Apo-2 Ligand, a New Member of the Tumor Necrosis Factor Cytokine Family
Pitti, R. M., Marsters, S. A., Ruppert, S., Donahue, C. J., Moore, A., & Ashkenazi, A. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12687 · Cited by 1,793
Self-citationControl of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors
Sheridan, J. P., Marsters, S. A., Pitti, R. M., Gurney, A., Skubatch, M., Baldwin, D., Ramakrishnan, L., Gray, C. L., Baker, K., Wood, W. I., et al. (1997) · Science · doi:10.1126/science.277.5327.818 · Cited by 1,664
Self-citationTargeting death and decoy receptors of the tumour-necrosis factor superfamily
Ashkenazi, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc821 · Cited by 1,360
Self-citationTargeting Apoptosis Pathways in Cancer Therapy
Ghobrial, I. M., Witzig, T. E., & Adjei, A. A. (2005) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.55.3.178 · Cited by 1,330
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Lowe, S. W., Cepero, E., & Evan, G. (2004) · Nature · doi:10.1038/nature03098 · Cited by 1,309
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.16.2060 · Cited by 1,268
Caspase Family Proteases and Apoptosis
Fan, T.-J., Han, L.-H., Cong, R.-S., & Liang, J. (2005) · Acta Biochimica et Biophysica Sinica · doi:10.1111/j.1745-7270.2005.00108.x · Cited by 1,246
Bid Induces the Oligomerization and Insertion of Bax into the Outer Mitochondrial Membrane
Eskes, R., Desagher, S., Antonsson, B., & Martinou, J.-C. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.3.929-935.2000 · Cited by 1,189
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
The CD95(APO-1/Fas) DISC and beyond
Peter, M. E., & Krammer, P. H. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401186 · Cited by 1,080
A Unified Model for Apical Caspase Activation
Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J.-E., Edris, W. A., Sutherlin, D. P., Green, D. R., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00051-0 · Cited by 968
Nagata, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4834 · Cited by 905
TRAIL and apoptosis induction by TNF-family death receptors
Wang, S., & El-Deiry, W. S. (2003) · Oncogene · doi:10.1038/sj.onc.1207232 · Cited by 871
Database of p53 gene somatic mutations in human tumors and cell lines.
Hollstein, M. C., Rice, K., Greenblatt, M. S., Soussi, T., Fuchs, R., Sørlie, T., Hovig, E. J., Smith‐Sørensen, B., Montesano, R., & Harris, C. C. (1994) · Europe PMC (PubMed Central) · Cited by 858
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Self-citationJo, M., Kim, T.-H., Seol, D.-W., Esplen, J. E., Dorko, K., Billiar, T. R., & Strom, S. C. (2000) · Nature Medicine · doi:10.1038/75045 · Cited by 843
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Self-citationTakeda, K., Hayakawa, Y., Smyth, M. J., Kayagaki, N., Yamaguchi, N., Kakuta, S., Iwakura, Y., Yagita, H., & Okumura, K. (2001) · Nature Medicine · doi:10.1038/83416 · Cited by 775
Fulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
Zhang, L., & Fang, B. (2005) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700792 · Cited by 702
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
Self-citationThe role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet
van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S. J., & Vandenabeele, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401088 · Cited by 665
A Small Molecule Smac Mimic Potentiates TRAIL- and TNFα-Mediated Cell Death
Li, L., Thomas, R. M., Suzuki, H., De Brabander, J. K., Wang, X., & Harran, P. G. (2004) · Science · doi:10.1126/science.1098231 · Cited by 656
Caspases: pharmacological manipulation of cell death
Lavrik, I. N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26252 · Cited by 644
CD4+ T-cell help controls CD8+ T-cell memory via TRAIL-mediated activation-induced cell death
Janssen, E. M., Droin, N. M., Lemmens, E. E., Pinkoski, M. J., Bensinger, S. J., Ehst, B. D., Griffith, T. S., Green, D. R., & Schoenberger, S. P. (2005) · Nature · doi:10.1038/nature03337 · Cited by 619
Wagner, K. W., Punnoose, E. A., Januario, T., Lawrence, D. A., Pitti, R. M., Lancaster, K., Lee, D., von Goetz, M., Yee, S. F., Totpal, K., et al. (2007) · Nature Medicine · doi:10.1038/nm1627 · Cited by 612
Self-citationDiagnosing and exploiting cancer's addiction to blocks in apoptosis
Letai, A. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2297 · Cited by 580
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
Almasan, A., & Ashkenazi, A. (2003) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(03)00029-7 · Cited by 553
Self-citationChemotherapy augments TRAIL-induced apoptosis in breast cell lines.
Keane, M., Ettenberg, S. A., Nau, M. M., RUSSELL, E. K., & Lipkowitz, S. (1999) · PubMed · Cited by 551
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Smyth, M. J., Cretney, E., Takeda, K., Wiltrout, R. H., Sedger, L. M., Kayagaki, N., Yagita, H., & Okumura, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.6.661 · Cited by 512
Varfolomeev, E. E., & Ashkenazi, A. (2004) · Cell · doi:10.1016/s0092-8674(04)00166-7 · Cited by 501
Self-citationKelley, S. K., Harris, L. A., Xie, D., DeForge, L., Totpal, K., Bussiere, J., & Fox, J. A. (2001) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29298-3 · Cited by 445
Hymowitz, S. G., Christinger, H. W., Fuh, G., Ultsch, M., O'Connell, M., Kelley, R. F., Ashkenazi, A., & de Vos, A. M. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80207-5 · Cited by 435
Self-citationThe 1993 Walter Hubert Lecture: the role of the p53 tumour-suppressor gene in tumorigenesis
Levine, A., Perry, M., Chang, A., Silver, A., Dittmer, D., Wu, M., & Welsh, D. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.76 · Cited by 422
Ashkenazi, A., Holland, P., & Eckhardt, S. G. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.7198 · Cited by 421
Self-citationInhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
Fulda, S., Meyer, E., & Debatin, K.-M. (2002) · Oncogene · doi:10.1038/sj.onc.1205258 · Cited by 394
Mitsiades, C. S., Treon, S. P., Mitsiades, N., Shima, Y., Richardson, P., Schlossman, R., Hideshima, T., & Anderson, K. C. (2001) · Blood · doi:10.1182/blood.v98.3.795 · Cited by 392
Apoptosis in the development and treatment of cancer
Gerl, R. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh283 · Cited by 385
Regulation of lymphocyte proliferation and death by flip
Thome, M., & Tschopp, J. (2001) · Nature Reviews Immunology · doi:10.1038/35095508 · Cited by 378
Targeting death receptors in cancer with Apo2L/TRAIL
KELLEY, S. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.02.006 · Cited by 370
Cuello, M. A., Ettenberg, S. A., Clark, A. S., Keane, M., Posner, R. H., Nau, M. M., Dennis, P. A., & Lipkowitz, S. (2001) · PubMed · Cited by 370
To kill a tumor cell: the potential of proapoptotic receptor agonists
Ashkenazi, A., & Herbst, R. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34359 · Cited by 323
Self-citationTolcher, A. W., Mita, M., Meropol, N. J., von Mehren, M., Patnaik, A., Padavic, K., Hill, M., Mays, T., McCoy, T., Fox, N. L., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.8898 · Cited by 314
Regulation of apoptosis in the immune system
Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., & Debatin, K.-M. (1994) · Current Opinion in Immunology · doi:10.1016/0952-7915(94)90102-3 · Cited by 308
Pukac, L., Kanakaraj, P., Humphreys, R., Alderson, R., Bloom, M., Sung, C., Riccobene, T., Johnson, R., Fiscella, M., Mahoney, A., et al. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602487 · Cited by 306
Kelley, R. F., Totpal, K., Lindstrom, S. H., Mathieu, M., Billeci, K., DeForge, L., Pai, R., Hymowitz, S. G., & Ashkenazi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410660200 · Cited by 284
Self-citationNakata, S., Yoshida, T., Horinaka, M., Shiraishi, T., Wakada, M., & Sakai, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207830 · Cited by 271
Sedger, L. M., Shows, D. M., Blanton, R. A., Peschon, J. J., Goodwin, R. G., Cosman, D. J., & Wiley, S. R. (1999) · PubMed · Cited by 270
Huntington, N. D., Puthalakath, H., Gunn, P., Naik, E., Michalak, E. M., Smyth, M. J., Tabarias, H., Degli-Esposti, M. A., Dewson, G., Willis, S. N., et al. (2007) · Nature Immunology · doi:10.1038/ni1487 · Cited by 268
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
Kaufmann, S. H., & Vaux, D. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206945 · Cited by 265
A Unique Zinc-Binding Site Revealed by a High-Resolution X-ray Structure of Homotrimeric Apo2L/TRAIL
Hymowitz, S. G., O'Connell, M. P., Ultsch, M. H., Hurst, A., Totpal, K., Ashkenazi, A., de Vos, A. M., & Kelley, R. F. (2000) · Biochemistry · doi:10.1021/bi992242l · Cited by 261
Self-citationGliniak, B., & Le, T. (1999) · PubMed · Cited by 261
Ricci, M. S., Kim, S.-H., Ogi, K., Plastaras, J. P., Ling, J., Wang, W., Jin, Z., Liu, Y. Y., Dicker, D. T., Chiao, P. J., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.006 · Cited by 255
The Apoptosome: Heart and Soul of the Cell Death Machine
Chinnaiyan, A. M. (1999) · Neoplasia · doi:10.1038/sj.neo.7900003 · Cited by 250
Phase 1 and Pharmacokinetic Study of Lexatumumab in Patients with Advanced Cancers
Plummer, R., Attard, G., Pacey, S., Li, L., Razak, A., Perrett, R., Barrett, M., Judson, I., Kaye, S., Fox, N. L., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0950 · Cited by 247
The role of receptor internalization in CD95 signaling
Lee, K., Feig, C., Tchikov, V., Schickel, R., Hallas, C., Schütze, S., Peter, M. E., & Chan, A. C. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601016 · Cited by 244
Direct Repression of FLIP Expression by c-myc Is a Major Determinant of TRAIL Sensitivity
Ricci, M. S., Jin, Z., Dews, M., Yu, D., Thomas-Tikhonenko, A., Dicker, D. T., & El-Deiry, W. S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.19.8541-8555.2004 · Cited by 243
The role of the Bcl-2 protein family in cancer
Coultas, L., & Strasser, A. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00129-3 · Cited by 242
Clancy, L., Mruk, K., Archer, K., Woelfel, M., Mongkolsapaya, J., Screaton, G., Lenardo, M. J., & Chan, F. K.-M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507329102 · Cited by 232
Sedger, L. M., Shows, D. M., Blanton, R. A., Peschon, J. J., Goodwin, R. G., Cosman, D., & Wiley, S. R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.2.920 · Cited by 232
Ligand-independent redistribution of Fas (CD95) into lipid rafts mediates clonotypic T cell death
Muppidi, J. R., & Siegel, R. M. (2004) · Nature Immunology · doi:10.1038/ni1024 · Cited by 227
Ganten, T. M., Koschny, R., Sykora, J., Schulze-Bergkamen, H., Büchler, P., Haas, T. L., Schader, M. B., Untergasser, A., Stremmel, W., & Walczak, H. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2635 · Cited by 217
Hamilton, S. E., Wolkers, M. C., Schoenberger, S. P., & Jameson, S. C. (2006) · Nature Immunology · doi:10.1038/ni1326 · Cited by 216
Current concepts in apoptosis: The physiological suicide program revisited
Chowdhury, I., Tharakan, B., & Bhat, G. (2006) · Cellular and Molecular Biology Letters · doi:10.2478/s11658-006-0041-3 · Cited by 216
TRAIL-R as a Negative Regulator of Innate Immune Cell Responses
Diehl, G. E., Yue, H. H., Hsieh, K., Kuang, A. A., Ho, M., Morici, L. A., Lenz, L. L., Cado, D., Riley, L. W., & Winoto, A. (2004) · Immunity · doi:10.1016/j.immuni.2004.11.008 · Cited by 212
Roth, W., Isenmann, S., Naumann, U., Kügler, S., Bähr, M., Dichgans, J., Ashkenazi, A., & Weller, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1693 · Cited by 208
Self-citationNimmanapalli, R., Perkins, C. L., Орландо, М., O'Bryan, E., Nguyen, D. N., & Bhalla, K. N. (2001) · PubMed · Cited by 201
Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines.
Harada, K., Toyooka, S., Shivapurkar, N., Maitra, A., Reddy, J., Matta, H., Miyajima, K., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., et al. (2002) · PubMed · Cited by 193
LaCour, S., Hammann, A., Wotawa, A., Corcos, L., Solary, É., & Dimanche‐Boitrel, M. (2001) · PubMed · Cited by 193
Grosse-Wilde, A., Voloshanenko, O., Bailey, S. L., Longton, G. M., Schaefer, U., Csernok, A. I., Schütz, G., Greiner, E. F., Kemp, C. J., & Walczak, H. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33061 · Cited by 190
Hotte, S. J., Hirte, H. W., Chen, E. X., Siu, L. L., Le, L. H., Corey, A., Iacobucci, A., MacLean, M., Lo, L., Fox, N. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1416 · Cited by 190
TRAIL-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis
Finnberg, N., Klein-Szanto, A. J. P., & El-Deiry, W. S. (2008) · Journal of Clinical Investigation · doi:10.1172/jci29900 · Cited by 180
TRAIL induces apoptosis in triple-negative breast cancer cells with a mesenchymal phenotype
Rahman, M., Davis, S. R., Pumphrey, J. G., Bao, J., Nau, M. M., Meltzer, P. S., & Lipkowitz, S. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9924-5 · Cited by 177
Naka, T., Sugamura, K., Hylander, B. L., Widmer, M. B., Rustum, Y. M., & Repasky, E. A. (2002) · PubMed · Cited by 174
Johnson, T. R., Stone, K., Nikrad, M. P., Yeh, T. C., Zong, W., Thompson, C. B., Nesterov, A., & Kraft, A. S. (2003) · Oncogene · doi:10.1038/sj.onc.1206656 · Cited by 173
Activation of Caspase-8 in the Alzheimer's Disease Brain
Rohn, T. T., Head, E., Nesse, W. H., Cotman, C. W., & Cribbs, D. H. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0449 · Cited by 171
Georgakis, G. V., Li, Y., Humphreys, R., Andreeff, M., O'Brien, S., Younes, M., Carbone, A., Albert, V., & Younes, A. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05656.x · Cited by 171
Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
Kim, M. S., Jeong, E. G., Yoo, N. J., & Lee, S. H. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604212 · Cited by 163
Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H. G., & Bhalla, K. (2002) · Blood · doi:10.1182/blood.v99.9.3419 · Cited by 162
Feig, C., Tchikov, V., Schütze, S., & Peter, M. E. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601460 · Cited by 160
Sharp, D. A., Lawrence, D. A., & Ashkenazi, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413962200 · Cited by 156
Self-citationCuello, M. A., Ettenberg, S. A., Nau, M. M., & Lipkowitz, S. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6194 · Cited by 152
Cysteine 230 Is Essential for the Structure and Activity of the Cytotoxic Ligand TRAIL
Bodmer, J.-L., Meier, P. F., Tschopp, J., & Schneider, P. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m909721199 · Cited by 151
Apoptosis, cancer and the p53 tumour suppressor gene
Lee, J. M., & Bernstein, A. (1995) · Cancer and Metastasis Reviews · doi:10.1007/bf00665797 · Cited by 149
Adams, C., Totpal, K., Lawrence, D., Marsters, S., Pitti, R., Yee, S., Ross, S., Deforge, L., Koeppen, H., Sagolla, M., et al. (2008) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402306 · Cited by 148
Self-citationTRAIL Inhibits Tumor Growth but Is Nontoxic to Human Hepatocytes in Chimeric Mice
Hao, C., Song, J. H., Hsi, B., Lewis, J. T., Song, D. K., Petruk, K. C., Tyrrell, D., & Kneteman, N. M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2599 · Cited by 147
Gulbins, E., Jekle, A., Ferlinz, K., Grassmé, H., & Lang, F. J. W. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.4.f605 · Cited by 142
Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling
El‐Deiry, W. S. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400943 · Cited by 139
Pharmacological manipulation of Bcl-2 family members to control cell death
Letai, A. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26250 · Cited by 134
Hyer, M. L., Croxton, R., Krajewska, M., Krajewski, S., Kress, C. L., Lü, M., Suh, N., Sporn, M. B., Cryns, V. L., Zapata, J. M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3319 · Cited by 132
Kohlhaas, S. L., Craxton, A., Sun, X.-M., Pinkoski, M. J., & Cohen, G. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700438200 · Cited by 130
Who Should Be Sent for Genetic Testing in Hereditary Colorectal Cancer Syndromes?
Lynch, H. T., Boland, C. R., Rodríguez-Bigas, M. A., Amos, C. I., Lynch, J. F., & Lynch, P. M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.3119 · Cited by 124
Pollack, I. F., Erff, M., & Ashkenazi, A. (2001) · PubMed · Cited by 118
Self-citationDeath to the bad guys: Targeting cancer via Apo2L/TRAIL
Bouralexis, S., Findlay, D. M., & Evdokiou, A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-6060-0 · Cited by 118
Rosato, R. R., Almenara, J. A., Coe, S., & Grant, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0598 · Cited by 118
Mcl-1: A Gateway to TRAIL Sensitization
Kim, S., Ricci, M., & El‐Deiry, W. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6278 · Cited by 114
Shankar, S., Singh, T. R., & Srivastava, R. K. (2004) · The Prostate · doi:10.1002/pros.20069 · Cited by 112
Jin, H., Yang, R., Fong, S., Tótpál, K., Lawrence, D. A., Zheng, Z., Ross, J., Koeppen, H., SCHWALL, R. H., & Ashkenazi, A. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0408 · Cited by 109
Self-citationHylander, B. L., Pitoniak, R., Penetrante, R. B., Gibbs, J. F., Oktay, D., Cheng, J., & Repasky, E. A. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-22 · Cited by 109
MCL-1 as a Buffer for Proapoptotic BCL-2 Family Members during TRAIL-induced Apoptosis
Meng, X. W., Lee, S. H., Dai, H., Loegering, D. A., Yu, C., Flatten, K. S., Schneider, P. A., Dai, N. T., Kumar, S. K., Smith, B. D., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m706110200 · Cited by 108
Ray, S., & Almasan, A. (2003) · PubMed · Cited by 108
Daniel, D., Yang, B., Lawrence, D. A., Tótpál, K., Balter, I., Lee, W. P., Gogineni, A., Cole, M. J., Yee, S. F., Ross, S., et al. (2007) · Blood · doi:10.1182/blood-2007-02-076075 · Cited by 106
Self-citationWang, S., & El‐Deiry, W. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1734 · Cited by 105
Caspases: A decade of death research
Thornberry, N. A. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400607 · Cited by 104
Motoki, K., Mori, E., Matsumoto, A., Thomas, M., Tomura, T., Humphreys, R. C., Albert, V. R., Muto, M., Yoshida, H., Aoki, M., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1867 · Cited by 103
Overexpression of FLIPL Is an Independent Marker of Poor Prognosis in Colorectal Cancer Patients
Ullenhag, G. J., Mukherjee, A., Watson, N. F., Al‐Attar, A., Scholefield, J. H., & Durrant, L. G. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2547 · Cited by 98
Mitsiades, N., Poulaki, V., Tseleni‐Balafouta, S., Koutras, D. A., & Stamenkovic, I. (2000) · PubMed · Cited by 97
Yu, R., Mandlekar, S., Ruben, S. M., Ni, J., & Kong, A. (2000) · PubMed · Cited by 92
Zhu, L.-J., Somlo, G., Zhou, B.-S., Shao, J., Bedell, V., Slovak, M., Liu, X.-Y., Luo, J.-H., & Yun, Y. (2005) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-04-0330 · Cited by 89
Apoptosis: a relevant tool for anticancer therapy
Russo, A. D., Terrasi, M., Agnese, V., Santini, D., & Bazan, V. (2006) · Annals of Oncology · doi:10.1093/annonc/mdl963 · Cited by 87
Bin, L., Thorburn, J., Thomas, L. R., Clark, P. E., Humphreys, R. C., & Thorburn, A. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704210200 · Cited by 83
Guo, Y., Chen, C., Zheng, Y., Zhang, J., Tao, X., Liu, S., Zheng, D., & Liu, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503621200 · Cited by 79
c‐Myc primed mitochondria determine cellular sensitivity to TRAIL‐induced apoptosis
Nieminen, A. I., Partanen, J. I., Hau, A., & Klefström, J. T. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601551 · Cited by 77
El-Zawahry, A. M., McKillop, J. C., & Voelkel‐Johnson, C. (2005) · BMC Cancer · doi:10.1186/1471-2407-5-2 · Cited by 75
Caspases in Huntington’s Disease
Mejia, R. O. S., & Friedlander, R. (2001) · The Neuroscientist · doi:10.1177/107385840100700604 · Cited by 70
Ravi, R. K., Jain, A. J., Schulick, R. D., Pham, V., Prouser, T. S., Allen, H. E., Mayer, E.-G., Yu, H., Pardoll, D. M., Ashkenazi, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2488 · Cited by 69
Self-citationSparano, J. A., Moulder, S. L., Kazi, A., Vahdat, L. T., Li, T., Pellegrino, C. M., Munster, P. N., Malafa, M. P., Lee, D., Hoschander, S., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.9114 · Cited by 68
Grünhagen, D. J., de Wilt, J. H. W., Graveland, W. J., van Geel, A. N., & Eggermont, A. M. M. (2005) · Cancer · doi:10.1002/cncr.21547 · Cited by 67
Hersh, E. M., Metch, B., Muggia, F. M., Brown, T. D., Whitehead, R. P., Budd, G. T., Rinehart, J. J., Crawford, E. D., Bonnet, J. D., & Behrens, B. C. (1991) · Journal of Immunotherapy · doi:10.1097/00002371-199112000-00006 · Cited by 65
Trail activity in human ovarian cancer cells
Vignati, S., Codegoni, A. M., Polato, F., & Broggini, M. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00345-8 · Cited by 65
Jin, H., Yang, R., Ross, J., Fong, S., Carano, R. A. D., Tótpál, K., Lawrence, D. A., Zheng, Z., Koeppen, H., Stern, H. M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0670 · Cited by 65
Self-citationSensitization of prostate carcinoma cells to Apo2L/TRAIL by a Bcl-2 family protein inhibitor
Ray, S., Bucur, O., & Almasan, A. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2490-y · Cited by 61
Proteasome inhibitors-mediated TRAIL resensitization and Bik accumulation
Zhu, H., Guo, W., Zhang, L., Wu, S., Teraishi, F., Davis, J. J., Dong, F., & Fang, B. (2005) · Cancer Biology & Therapy · doi:10.4161/cbt.4.7.1897 · Cited by 61
Synergistic cytotoxicity and apoptosis by Apo-2 ligand and adriamycin against bladder cancer cells.
Mizutani, Y., Yoshida, O., Miki, T., & Bonavida, B. (1999) · PubMed · Cited by 59
Hayakawa, K., Takemura, G., Koda, M., Kawase, Y., Maruyama, R., Li, Y., Minatoguchi, S., Fujiwara, T., & Fujiwara, H. (2002) · Circulation · doi:10.1161/01.cir.0000018651.89208.69 · Cited by 57
Frese, S., Brunner, T., Gugger, M., Uduehi, A. N., & Schmid, R. A. (2002) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2002.119694 · Cited by 56
Zhang, L., Zhang, X., Barrisford, G. W., & Olumi, A. F. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.11.013 · Cited by 54
Jönsson, G., Paulie, S., & Grandien, A. (2003) · PubMed · Cited by 51
Xiang, H., Fox, J. A., Tótpál, K., Aikawa, M., DuPree, K., Sinicropi, D. V., Lowe, J. R., & Escandón, E. (2002) · Oncogene · doi:10.1038/sj.onc.1205449 · Cited by 50
LoRusso, P. M., Hong, D. S., Heath, E. I., Kurzrock, R., Wang, D., Hsu, M. L., Goyal, L., Wiezorek, J. S., Storgard, C. M., & Herbst, R. S. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.3534 · Cited by 50
Sikic, B. I., Wakelee, H. A., von Mehren, M., Lewis, N. L., Calvert, H., Plummer, E. R., Fox, N. L., Howard, T., Jones, S. F., & Burris, H. A. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.14006 · Cited by 49
DR5 Receptor Mediates Anoikis in Human Colorectal Carcinoma Cell Lines
Laguinge, L. M., Samara, R. N., Wang, W., El‐Deiry, W. S., Corner, G. A., Augenlicht, L. H., Mishra, L., & Jessup, J. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-06-1806 · Cited by 46
16th World Conference on Lung Cancer
Nielsen, T. B., Brink, C., Sloth Møller, D., Hoffmann, L., Lutz, C. M., Appelt, A. L., Lund, M. D., Nielsen, M. S., Sibolt, P., Larsen, C., et al. (2015) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000473439.77589.a7 · Cited by 45
Poh, T. W., Huang, S., Hirpara, J. L., & Pervaiz, S. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402177 · Cited by 42
Brooks, A. D., RAMIREZ, T., Toh, U., Onksen, J. L., Elliott, P. J., Murphy, W. J., & Sayers, T. J. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1339.042 · Cited by 38
Sikic, B. I., Wakelee, H. A., von Mehren, M., Lewis, N. L., Plummer, E. R., Calvert, H., Fox, N. L., Kumm, E., Jones, S. F., & Burris, H. A. (2007) · UCL Discovery (University College London) · Cited by 36
Cytogenetic evolution of follicular lymphoma
Viardot, A., Barth, T. F. E., Mӧller, P., Döhner, H., & Bentz, M. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(03)00014-2 · Cited by 36
Cloning and expression of rat caspase-6 and its localization in renal ischemia/reperfusion injury
Singh, A. B., Kaushal, V., Megyesi, J. K., Shah, S. V., & Kaushal, G. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00427.x · Cited by 35
Apoptosis and Autoimmune Disorders
Prasad, K. V. S., & Prabhakar, B. S. (2003) · Autoimmunity · doi:10.1080/08916930310001604207 · Cited by 35
Chow, L. Q. M., Eckhardt, S. G., Gustafson, D. L., O’Bryant, C. L., Hariharan, S., Diab, S., Fox, N. L., Corey, A. E., Padavic, K., Brown, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.2515 · Cited by 34
Mechanisms of lymphocyte killing by HIV
Casella, C. R., & Finkel, T. H. (1997) · Current Opinion in Hematology · doi:10.1097/00062752-199704010-00005 · Cited by 32
Patnaik, A., Wakelee, H. A., Mita, M. M., Fitzgerald, A., Hill, M., Fox, N. L., Howard, T., Ullrich, S. J., Tolcher, A. W., & Sikic, B. I. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.3012 · Cited by 27
Ou, D., Wang, X., Metzger, D. L., James, R. F. L., Pozzilli, P., Plesner, A., Korneluk, R. G., Verchere, C. B., & Tingle, A. J. (2005) · Human Immunology · doi:10.1016/j.humimm.2004.12.002 · Cited by 25
Use of APO2L/TRAIL with mTOR inhibitors in the treatment of glioblastoma multiforme
Panner, A., Parsa, A. T., & Pieper, R. O. (2006) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.6.9.1313 · Cited by 25
Sharma, S., de Vries, E. G. E., Infante, J. R., Oldenhuis, C. N. A. M., Chiang, L., Bilic, S., Goldbrunner, M., Scott, J. W., & Burris, H. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3538 · Cited by 25
Wang, Y., Quon, K. C., & Knee, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2757 · Cited by 23
Drug evaluation: lexatumumab, an intravenous human agonistic mAb targeting TRAIL receptor 2.
Marini, P. (2006) · PubMed · Cited by 22
Induction of apoptosis by recombinant soluble human TRAIL in Jurkat cells.
Yao, G., Ling, L.-J., Luan, J., et al. (2007) · PubMed · Cited by 7
Cited by
Targeting apoptosis in cancer therapy
Carneiro, B. A., & El-Deiry, W. S. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0341-y · Cited by 2,542
Keratins in health and cancer: more than mere epithelial cell markers
Karantza, V (2011) · Oncogene · doi:10.1038/onc.2010.456 · Cited by 536
Herbst, R. S., Eckhardt, S. G., Kurzrock, R., Ebbinghaus, S., O'Dwyer, P. J., Gordon, M. S., Novotny, W., Goldwasser, M. A., Tohnya, T. M., Lum, B. L., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.25.1991 · Cited by 446
Self-citationDimitrov, D. S. (2012) · Methods in Molecular Biology · doi:10.1007/978-1-61779-921-1_1 · Cited by 347
The concept of intrinsic versus extrinsic apoptosis
Lossi, L. (2022) · Biochemical Journal · doi:10.1042/bcj20210854 · Cited by 329
Metadata
- Authors
- Ashkenazi, A.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2008-11-07
- Volume
- 7
- Issue
- 12
- Pages
- 1001-1012
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2079463756
- Cited by
- 432
- References
- 167
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.